Journal Home > Volume 1 , Issue 2
iLIVER 2022, 1(2): 96-100 https://doi.org/10.1016/j.iliver.2022.07.001
Review | Open Access | Issue | Published: 01 August 2022

Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management

Show Author's Information Jia Fu,  Shou-jin Cao,  Li Song,  Xiao-qiang Tong,  Jian Wang,  Min Yang,  Ying-hua Zou( )
Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China
Keywords:
Magnetic resonance imaging, Hepatocellular carcinoma, Computed tomography, Quantitative imaging
Cite this article:
Fu J, Cao S-j, Song L, et al. Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management. iLIVER, 2022, 1(2): 96-100. https://doi.org/10.1016/j.iliver.2022.07.001
Download citation
EndNote(RIS)
BibTeX

472

Views

Citations

5

Crossref

N/A

WoS

N/A

Scopus

N/A

CSCD

Abstract About this article

Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide. Recently, radiomics and radiogenomics have been introduced as novel dimensions in oncology research. In the current review, we summarize the clinical applications of radiomics and radiogenomics in hepatocellular carcinoma.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 31 May 2022
Revised: 06 July 2022
Accepted: 11 July 2022
Published: 01 August 2022
Issue date: June 2022

Copyright

© 2022 Published by Elsevier Ltd on behalf of Tsinghua University Press.

Acknowledgements

The authors thank Ying-hua Zou, for the help in editing this manuscript.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return